Phase 1 Allogeneic Stem Cell Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Donor-Derived Viral Specific T-cells (VSTs)

Viral reactivationallogeneic stem cell transplantViral Infection

Children's Hospital Medical Center, Cincinnati750 enrolled3 locationsNCT02048332

Not Yet Recruiting

Phase 1

A phase 1 multicentre open label dose-escalation study of unrelated, major histocompatibility (MHC)-unmatched mesenchymals stem cells (MSC) for the treatment of steroid refractory acute graft versus host disease in recipients of allogeneic heamatopoietic stem cell transplants

Patients who have undergone a allogeneic stem cell transplant who have developed steroid refractory graft versus host disease

Mater Medical Research Institute9 enrolled1 locationACTRN12607000430437